Mineralys Therapeutics, Inc.

SEC 4 · Filed

0001693134-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 12, 2026

Sale by Levy Adam Scott

Security
Common Stock
Code
S
Shares
10,758
Price per share
32.14Reported 32.1364
Structured facts
{
  "code": "S",
  "date": "2026-01-12",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023.",
    "F2": "The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.90 to $32.37. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."
  },
  "owners": [
    {
      "cik": "0001693134",
      "name": "Levy Adam Scott",
      "roles": [
        "officer"
      ],
      "title": "CFO and Secretary"
    }
  ],
  "ownership": "D",
  "post_shares": "8638",
  "price": "32.1364",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "10758",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}